• Tidak ada hasil yang ditemukan

Hemodynamic Evaluation

Dalam dokumen Moyamoya Disease Update (Halaman 171-175)

164 K. Nishino et al.

anastomosis on the cortical surface or a transdural anastomosis via a vault or ethmoidal moyamoya.

Furthermore, it is also difficult to ascertain the detailed course of STA which is important information for harvesting STA for direct bypass.

165 MRI

mapping can be obtained by rapidly manipulating end-tidal PCO 2 between a hypercapnic and hypocapnic state (30–50 mmHg), and the map is capable of revealing the presence and spatial extent of exhausted autoregulation [13] .

Conclusions

Early diagnosis and appropriate treatment are crucial to improve the long-term outcome for cases with moyamoya disease. Although the imaging quality of MRI/MRA is still inferior to the existing modalities in some aspects, future progress of the technology will increase the role of MRI/MRA in the management of moyamoya disease.

References

1. Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99:238–240

Fig. 8 Preoperative MRA (infero-lateral view ( a ), coronal view ( b )) shows occlusion in the terminal of bilateral ICA ( arrowheads ) and development of moyamoya vessels ( arrow ). MRA (infero-lateral view ( c ), coronal view ( d )) obtained 4 months after combined bypass surgery reveals an increase in the diameter of the superficial temporal artery and deep temporal arteries ( arrows ) as well as the remission of moyamoya vessels

166 K. Nishino et al.

2. Kuroda S, Hashimoto N, Yoshimoto T et al (2007) Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38:1430–1435 3. Kuroda S, Houkin K (2008) Moyamoya disease: current concept and future perspectives. Lancet

Neurol 7:1056–1066

4. Kuriyama S, Kusaka Y, Fujimura M et al (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: Findings from a nationwide epidemiological survey. Stroke 39:42–47

5. Baba T, Houkin K, Kuroda S (2007) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900–904

6. Kurokawa T, Tomita S, Ueda K et al (1985) Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1:274–277

7. Imaizumi T, Hayashi K, Saito K et al (1998) Long-term outcome of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 18:321–325

8. Imaizumi C, Imaizumi T, Osawa M et al (1999) Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 30:294–299

9. Houkin K, Nakayama N, Kuroda S et al (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20:347–354

10. Lee SK, Kim DI, Jeong EK et al (2003) Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience. Am J Neuroradiol 24:741–747

11. Togao O, Mihara F, Yoshiura T et al (2006) Cerebral hemodynamics in moyamoya disease:

correlation between perfusion-weighted MR imaging and cerebral angiography. Am J Neuroradiol 27:391–397

12. Yun TJ, Cheon JE, Na DG et al (2009) Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging: correlation with clinical outcome after revascularization surgery. Radiology 251:216–223

13. Mikulis DJ, Krolczyk G, Desal H et al (2005) Preoperative and postoperative mapping of cerebro- vascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. J Neurosurg 103:347–355

14. Bacigaluppi S, Dehdashti AR, Agid R et al (2009) The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease. Neurorsurg Focus 26:E3

15. Takahashi A, Fujiwara S, Suzuki J (1986) Long-term followup angiography of moyamoya disease-cases followed from childhood to adolescence. No Shinkei Geka 14:23–29

16. Ezura M, Yoshimoto T, Fujiwara S et al (1995) Clinical and angiographic follow-up of childhood- onset moyamoya disease. Childs Nerv Syst 11:591–594

17. Kim SK, Seol HJ, Cho BK et al (2004) Moyamoya disease among young patients: its clinical course and the role of active surgical treatment. Neurosurgery 54:840–844

18. Smith ER, Scott RM (2008) Progression of disease in unilateral moyamoya disease. Neurosurg Focus 24:E17

19. Kelly ME, Bell-Stephens TE, Marks MP (2006) Progression of unilateral moyamoya disease: a clini- cal series. Cerebrovasc Dis 22:109–115

20. Kuroda S, Ishikawa T, Houkin K et al (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148–2153

21. Hasuo K, Mihara F, Matsushima T (1998) MRI and MR angiography in moyamoya disease. J Magn Reson Imaging 8:762–766

22. Maeda M, Tsuchida C (1999) “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. Am J Neuroradiol 20:1836–1838

23. Yoon HK, Shin HJ, Chang YW (2002) “Ivy sign” in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. Radiology 223:384–389

24. Fujiwara H, Momoshima S, Kuribayashi S (2005) Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 55:224–230

25. Maeda M, Yagishita A, Yamamoto T et al (2003) Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: a spectrum of central nervous system disease. Eur Radiol 13 (4 Suppl):L192–L201

26. Tosaka M, Sato N, Fujimaki H et al (2008) Diffuse pachymeningeal hyperintensity and subdural effusion/hematoma detected by fluid-attenuated inversion recovery MR imaging in patient with spontaneous intracranial hypotension. Am J Neuroradiol 29:1164–1170

167 MRI

27. Ishikawa T, Kuroda S, Nakayama N et al (2005) Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir 45:495–500

28. Kikuta K, Takagi Y, Nozaki K et al (2005) Asymptomatic microbleeds in moyamoya disease:

T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102:470–475 29. Kikuta K, Takagi Y, Nozaki K et al (2008) The presence of multiple microbleeds as a predictor of

subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery 62:104–110 30. Harada A, Fujii Y, Yoneoka Y et al (2001) High-field magnetic resonance imaging in patients with

moyamoya disease. J Neurosurg 94:233–237

31. Gravel JH, Levine M, Hollis P et al (1989) Moyamoya-like disease associated with a lenticulostriate region aneurysm. J Neurosurg 70:802–803

32. Lee JK, Lee KH, Kim SH et al (2001) Distal anterior choroidal artery aneurysm in a patient with moyamoya disease: case report. Neurosurgery 48:222–225

33. Iwama T, Morimoto M, Hashimoto N et al (1997) Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg 99:S187–S190

34. Kawaguchi S, Sakaki T, Morimoto T et al (1996) Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir (Wien) 138:1287–1294

35. Iwama T, Todaka T, Hashimoto N (1997) Direct surgery for major artery aneurysm associated with moyamoya disease. Clin Neurol Neurosurg 99:S191–S193

36. Wiesmann M, Mayer TE, Madele R et al (2002) Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg 96:684–689

37. Yuank MK, Lai PH, Chen JY et al (2005) Detection of subarachnoid hemorrhage at acute and subacute/chronic stages: comparison of four magnetic resonance imaging pulse sequences and computed tomography. J Clin Med Assoc 68:131–137

38. Özsarlak Ö, Van Goethem JW, Parizel PM (2004) MR angiography of the intracranial vessels:

technical aspects and clinical applications. Neuroradiology 46:955–972

39. Tsuchiya K, Fujikawa A, Tateishi H et al (2005) Postoperative assessment of extracranial-intracranial bypass by time-resolved 3D contrast-enhanced MR angiography using parallel imaging. Am J Neuroradiol 26:2243–2247

40. Houkin K, Aoki T, Takahashi A et al (1994) Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 25:2159–2164

41. Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya disease”. Disease showing abnormal net-like vessels in base of the brain. Arch Neurol 20:288–299

42. Kuroda S, Ishikawa T, Houkin K et al (2002) Clinical significance of posterior cerebral artery stenosis/

occlusion in moyamoya disease. No Shinkei Geka 30:1295–1300

43. Mugikura S, Takahashi S, Higano S et al (1999) The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. Am J Neuroradiol 20:336–343 44. Yamada I, Himeno Y, Suzuki S et al (1995) Posterior circulation in moyamoya disease: angiographic

study. Radiology 197:239–246

45. Irikura K, Miyasaka Y, Tanaka R et al (1996) A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138:1282–1286

46. Morioka M, Hamada J, Kawano T et al (2003) Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34:90–95

47. Honda M, Kitagawa N, Tsutsumi K et al (2005) Magnetic resonance angiography evaluation of external carotid artery tributaries in moyamoya disease. Surg Neurol 64:325–330

48. Houkin K, Nakayama N, Kuroda S et al (2004) How does angiogenesis develop in pediatric moyamoya disease after surgery? Childs Nerv Syst 20:734–741

49. Yoon HK, Shin HJ, Lee M et al (2000) MR angiography of moyamoya disease before and after encephaloduroarteriosynangiosis. Am J Radiol 174:195–200

50. Fushimi Y, Miki Y, Kikuta K et al (2006) Comparison of 3.0- and 1.5-T three-dimensional time-of- flight MR angiography on moyamoya disease: preliminary experience. Radiology 239:232–237 51. Tomasian A, Salamon N, Lohan DG et al (2008) Supraaortic arteries: contrast material doze reduction

at 3.0-T high spatial resolution MR angiography-Feasibility study. Radiology 249:980–990

Part VIII

Dalam dokumen Moyamoya Disease Update (Halaman 171-175)